TP53 and prostate cancer: In conclusion, the JE containing several plant phenolic compounds activated cell death in a dose-dependent manner in A549 non-small lung cancer, HepG2 hepatocarcinoma, and 22RV1 and DU145 prostate cancer cells through inhibition of PI3K/Akt and activation of p53 pathways.